Estimating the societal cost of type 2 diabetes in Malmö, Sweden: a register-based cost analysis
These findings may support city-level healthcare planning and preventive interventions, as Malmö is facing substantial costs both in monetary terms and in reduced quality of life. Younger persons increasingly develop diabetes complications, which needs to be considered when allocating resources for primary prevention, treatment of complications, and municipality costs within a near future.
Authors
- Magdalena Annersten Gershater (ORCID: https://orcid.org/0000-0003-4395-2522)
- Alexander Dozet
- Åsa Ericsson (ORCID: https://orcid.org/0000-0002-3226-7469)
- Slobodan Zdravkovic (ORCID: https://orcid.org/0000-0002-8491-4349)
Institutions
- Malmö University (SE)
- Novo Nordisk (Denmark) (DK)
- Skåne University Hospital (SE)
Publication Details
- Journal
- Frontiers in Clinical Diabetes and Healthcare
- Published
- 2025-12-03
- DOI
- https://doi.org/10.3389/fcdhc.2025.1611426
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 0.00